Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection

<p>Abstract</p> <p>Arbidol (ARB) is an antiviral compound that was originally proven effective for treatment of influenza and several other respiratory viral infections. The broad spectrum of ARB anti-viral activity led us to evaluate its effect on hepatitis C virus (HCV) infection...

Full description

Bibliographic Details
Main Authors:	Pécheur Eve-Isabelle, Boriskin Yury S, Polyak Stephen J
Format:	Article
Language:	English
Published:	BMC 2006-07-01
Series:	Virology Journal
Online Access:	http://www.virologyj.com/content/3/1/56

Similar Items

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.
by: Elodie Teissier, et al.
Published: (2011-01-01)

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
by: Jan Haviernik, et al.
Published: (2018-04-01)

Broad-spectrum antiviral therapeutics.
by: Todd H Rider, et al.
Published: (2011-01-01)

Broad-spectrum antiviral agents
by: Jun-Da eZhu, et al.
Published: (2015-05-01)

Broad-Spectrum Antiviral Therapeutics
by: Rider, Todd H., et al.
Published: (2011)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
by: Robert J. Geraghty, et al.
Published: (2021-04-01)

Mucin Biopolymers As Broad-Spectrum Antiviral Agents
by: Lieleg, Oliver, et al.
Published: (2014)

Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
by: Lisa Oestereich, et al.
Published: (2014-05-01)

Crystal Structures, Thermal Analysis, and Dissolution Behavior of New Solid Forms of the Antiviral Drug Arbidol with Dicarboxylic Acids
by: Alex N. Manin, et al.
Published: (2015-12-01)

Experience in application Arbidol disease area rotavirus
by: V. V. Malyshev, et al.
Published: (2014-09-01)

Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
by: Elodie Teissier, et al.
Published: (2010-12-01)

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells
by: Fausto Nelson, et al.
Published: (2005-12-01)

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
by: Chunguang Yang, et al.
Published: (2020-05-01)

Discovery and development of safe-in-man broad-spectrum antiviral agents
by: Petter I. Andersen, et al.
Published: (2020-04-01)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
by: Michela Mazzon, et al.
Published: (2019-02-01)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition.
by: John L Goodier, et al.
Published: (2015-05-01)

Computer-aided drug design of broad-spectrum antiviral compounds
by: Klimenko, Kyrylo
Published: (2017)

Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease
by: O N Titova, et al.
Published: (2018-08-01)

Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease
by: O.N. Titova, et al.
Published: (2018-08-01)

Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
by: Patrick Maillard, et al.
Published: (2011-01-01)

Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
by: Peng Yin, et al.
Published: (2021-07-01)

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
by: Hailong Li, et al.
Published: (2021-01-01)

Preparation and evaluation of taste masked oral suspension of arbidol hydrochloride
by: Ling Wang, et al.
Published: (2015-02-01)

Étude des mécanismes moléculaires des inhibiteurs de l'entrée du virus de l'hépatite C (HCV) Silibinine et Arbidol : microenvironnement hépatique et infection par le HCV
by: Blaising, Julie Élisabeth Françoise
Published: (2013)

Massively-Parallel Computational Identification of Novel Broad Spectrum Antivirals to Combat Coronavirus Infection
by: Berry, Michael
Published: (2021)

Inhibition of HCV replication by host cell innate antiviral defences
by: Al-Hababi, Fadhil H.
Published: (2010)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
by: Julia L. Casey, et al.
Published: (2019-04-01)

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target
by: Shuofeng Yuan, et al.
Published: (2019-01-01)

Discovery of potent broad spectrum antivirals derived from marine actinobacteria.
by: Avi Raveh, et al.
Published: (2013-01-01)

Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
by: David A. Jans, et al.
Published: (2020-09-01)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
by: Jason A. Wojcechowskyj, et al.
Published: (2010-05-01)

Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors
by: Deemah Dabbagh, et al.
Published: (2021-05-01)

Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.
by: Jessica Wagoner, et al.
Published: (2011-01-01)

The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection
by: Marcello Persico, et al.
Published: (2011-01-01)

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
by: Marzieh Nojomi, et al.
Published: (2020-12-01)

Antiviral therapy in HCV-infected decompensated cirrhotics
by: Danish Fazal, et al.
Published: (2010-01-01)

A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope
by: Rutger D. Luteijn, et al.
Published: (2020-08-01)

Antidepessant sertraline act as a broad-spectrum antiviral agent against enteroviruses.
by: Ya-Cing Liang, et al.
Published: (2018)

Development of Broad-Spectrum Antiviral Agents—Inspiration from Immunomodulatory Natural Products
by: Mengxun Zhang, et al.
Published: (2021-06-01)

A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.
by: Frederic Vigant, et al.
Published: (2013-01-01)